Trial Profile
Incidence of skin reactions in patients with hepatitis C receiving telaprevir in a single tertiary centre.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 24 Aug 2015 New trial record